Now open: The JPIAMR Joint Call “Disrupting drug Resistance Using Innovative Design”
JPIAMR launches its 14th call. CHF 600,000 has been budgeted for Swiss project partners.
The call focuses on tackling the rising threat of antimicrobial resistance. Declining effectiveness of existing antimicrobials together with the insufficiently low number of promising new antimi-crobials in the pipeline underlines the urgency of developing new protocols and innovative ap-proaches for effective delivery and use of the already existing antimicrobials.
The aim is to im-prove the treatment of bacterial and fungal infections (including co-infection) and/or to help prevent the emergence/spread of resistance in humans, animals or plants by enhancing the efficacy, specificity, delivery, combinations and/or repurposing of drugs and plant protection agents.
The call involves 26 funding organisations from 17 countries. The total estimated call budget is 17 million euros.
The project teams should comprise three to six partners from different countries. The SNSF has set aside 600,000 francs for the Swiss partners in these teams.
Applicants from Switzerland must be eligible for the SNSF's project funding scheme. Along with the JPIAMR application, they need to submit an administrative application to the SNSF via mySNF (under Partnerships/JPIAMR).
Proposals will be evaluated in a two-step procedure (pre-proposals/full proposals), and appli-cants have until 8 March 2022, 14:00 (CET) to submit their pre-proposals.
A webinar about the call will be held on 25 January at 16:00 CET. Please register via link below.
A match-making tool has been created for applicants, to facilitate networking and the creation of consortia. The multi-purpose tool will be launched on 11 January 2022.
The application documents and further information can be found on the call’s webpage (see link below).